Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2915)
All Articles published online
|
Nov 21, 2006 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu DL, Sui FY, Jiang XM, Jiang XH. Methylation in esophageal carcinogenesis. World J Gastroenterol 2006; 12(43): 6933-6940 [PMID: 17109513 DOI: 10.3748/wjg.v12.i43.6933] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i43/6933.htm |
| Number | Citing Articles |
| 1 |
Zaur Hamidov, Annelore Altendorf-Hofmann, Yuan Chen, Utz Settmacher, Iver Petersen, Thomas Knösel. Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. Journal of Clinical Pathology 2011; 64(11): 990 doi: 10.1136/jclinpath-2011-200099
|
| 2 |
Lawrence R. Kleinberg, Malcolm V. Brock, Sanjay B. Jagannath, Arlene A. Forastiere. Abeloff's Clinical Oncology. 2008; : 1399 doi: 10.1016/B978-0-443-06694-8.50082-8
|
| 3 |
Lisa Adams, Mark J. Roth, Christian C. Abnet, Sonja P. Dawsey, You-Lin Qiao, Guo-Qing Wang, Wen-Qiang Wei, Ning Lu, Sanford M. Dawsey, Karen Woodson. Promoter Methylation in Cytology Specimens as an Early Detection Marker for Esophageal Squamous Dysplasia and Early Esophageal Squamous Cell Carcinoma. Cancer Prevention Research 2008; 1(5): 357 doi: 10.1158/1940-6207.CAPR-08-0061
|
| 4 |
Eun Ju Lee, Bo Bin Lee, Joungho Han, Eun Yoon Cho, Young Mog Shim, Joobae Park, Duk‐Hwan Kim. CpG island hypermethylation of E‐cadherin (CDH1) and integrin α4 is associated with recurrence of early stage esophageal squamous cell carcinoma. International Journal of Cancer 2008; 123(9): 2073 doi: 10.1002/ijc.23598
|
| 5 |
Ramona G. Dumitrescu. Cancer Epidemiology. Methods in Molecular Biology 2009; 471: 457 doi: 10.1007/978-1-59745-416-2_23
|
| 6 |
Joanne P. Young, Peter W. Laird. Genetics of Colorectal Cancer. 2009; : 73 doi: 10.1007/978-0-387-09568-4_4
|
| 7 |
Hironobu Shigaki, Yoshifumi Baba, Masayuki Watanabe, Shiro Iwagami, Keisuke Miyake, Takatsugu Ishimoto, Masaaki Iwatsuki, Hideo Baba. LINE-1 Hypomethylation in Noncancerous Esophageal Mucosae is Associated with Smoking History. Annals of Surgical Oncology 2012; 19(13): 4238 doi: 10.1245/s10434-012-2488-y
|
| 8 |
Oliver J. Pickering, Stella P. Breininger, Timothy J. Underwood, Zoë S. Walters. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma. Cancers 2021; 13(16): 4084 doi: 10.3390/cancers13164084
|
| 9 |
Chen Chen, Ni Yin, Bangliang Yin, Qianjin Lu. DNA methylation in thoracic neoplasms. Cancer Letters 2011; 301(1): 7 doi: 10.1016/j.canlet.2010.10.017
|
| 10 |
Wei Guo, Guiying Wang, Yuran Dong, Yanli Guo, Gang Kuang, Zhiming Dong. Decreased expression of WWOX in the development of esophageal squamous cell carcinoma. Molecular Carcinogenesis 2013; 52(4): 265 doi: 10.1002/mc.21853
|
| 11 |
Wei Guo, Zhiming Dong, Xinwen Lin, Minghui Zhang, Gang Kuang, Tienian Zhu. Decreased Expression and Aberrant Methylation of Raf Kinase Inhibitory Protein Gene in Esophageal Squamous Cell Carcinoma. Cancer Investigation 2012; 30(10): 703 doi: 10.3109/07357907.2012.732164
|
| 12 |
Wang-Kai Fang, Wei Gu, En-Min Li, Zhi-Yong Wu, Zhong-Ying Shen, Jin-Hui Shen, Jian-Yi Wu, Feng Pan, Zhuo Lv, Xiu-E Xu, Qiao Huang, Li-Yan Xu. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor. Human Pathology 2010; 41(10): 1456 doi: 10.1016/j.humpath.2010.04.003
|
| 13 |
C. Hennequin, L. Quero, V. Baruch-Hennequin, C. Maylin. Faut-il encore opérer les cancers de l’œsophage localement évolués ?. Cancer/Radiothérapie 2008; 12(8): 831 doi: 10.1016/j.canrad.2008.05.005
|
| 14 |
Matthew Koshy, Bruce D. Greenwald, Petr Hausner, Mark J. Krasna, Naomi Horiba, Richard J. Battafarano, Whitney Burrows, Mohan Suntharalingam. Outcomes After Trimodality Therapy for Esophageal Cancer. American Journal of Clinical Oncology 2011; 34(3): 259 doi: 10.1097/COC.0b013e3181e841ce
|
| 15 |
Javad Mohammadi-Asl. Epigenetics Territory and Cancer. 2015; : 479 doi: 10.1007/978-94-017-9639-2_15
|
| 16 |
Jurjen J Boonstra, Winand NM Dinjens, Hugo W Tilanus, Linetta B Koppert. Molecular biological challenges in he treatment of esophageal adenocarcinoma. Expert Review of Gastroenterology & Hepatology 2007; 1(2): 275 doi: 10.1586/17474124.1.2.275
|
| 17 |
Lawrence Kleinberg, Arlene A. Forastiere. Chemoradiation in the Management of Esophageal Cancer. Journal of Clinical Oncology 2007; 25(26): 4110 doi: 10.1200/JCO.2007.12.0881
|
| 18 |
Toshiyuki Sakaeda, Motohiro Yamamori, Akiko Kuwahara, Kohshi Nishiguchi. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy. Advanced Drug Delivery Reviews 2009; 61(5): 388 doi: 10.1016/j.addr.2008.10.005
|